Antonis E Koromilas
Full Member, McGill Centre for Translational Research in Cancer
Professor, Department of Oncology, Faculty of Medicine, McGill University
Associate Member, Department of Medicine, Division of Experimental Medicine, McGill University
Senior Investigator and Project Director, Molecular Oncology, Lady Davis Institute for Medical Research
Dr. Koromila's research program focuses on the study of translational and signaling properties of the phosphorylation of the α subunit the translation initiation factor eIF2 at serine 51 (eIF2αS51P) in stress responses associated with tumor formation and treatment with chemotherapeutic drugs. His team also investigates the cell-autonomous function of the transcription factor Stat1 in the inhibition of oncogenic pathways in tumor cells and regulation of tumor responses to treatments with anti-tumor drugs.
